Structured Summary
Abstract
Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
9 entry terms
- Drugs, Investigational
- Investigational Drug
- Investigational New Drug
- Investigational New Drugs
- Drug, Investigational
- Drug, Investigational New
- Drugs, Investigational New
- New Drug, Investigational
- New Drugs, Investigational
MeSH Record
Aspects Covered
18 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, chemical synthesis, chemistry, classification, economics, history, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity.
MeSH Record
Indexing Annotation
coordinate with specific drug; not restricted to FDA studies: may be used for investigational drugs in other countries
MeSH Record
History Note
90
MeSH Record
Previous Indexing
- Clinical Trials (1966-1989)
- Drug Evaluation (1974-1989)
- Drugs (1966-1989)
MeSH Hierarchy
Tree Number
- D26.371
AMA Style
References
- National Library of Medicine. Investigational Drugs. Medical Subject Headings (MeSH). 2026. Unique ID D015507. http://id.nlm.nih.gov/mesh/2026/D015507
- Investigational Drugs. In: Wikidata. https://www.wikidata.org/wiki/Q76797059